A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer. [electronic resource]
Producer: 19920626Description: 479-81 p. digitalISSN:- 0959-8049
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cisplatin -- administration & dosage
- Drug Evaluation
- Etoposide -- administration & dosage
- Female
- Humans
- Infusions, Parenteral
- Injections, Intravenous
- Leukopenia -- chemically induced
- Middle Aged
- Ovarian Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.